tm logo
NTX
Live/Registered
REGISTERED

on 21 Jan 2020

Last Applicant/ Owned by

6401 RICHARDS AVENUE

SANTA FE

NM

87508

Serial Number

87899064 filed on 28th Apr 2018

Registration Number

5968170 registered on 21st Jan 2020

in the Principal Register

Correspondent Address

DAVID KERR

BERG HILL GREENLEAF AND RUSCITTI, LLP

1712 PEARL

BOULDER CO 80302

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NTX

Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a Read More

Classification Information


Class [040]
Treatment & Processing of Materials Services


Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules


First Use Date in General

16th Aug 2018

First Use Date in Commerce

16th Aug 2018

Class [042]
Computer & Software Services & Scientific Services


Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data


First Use Date in General

16th Aug 2018

First Use Date in Commerce

16th Aug 2018

Mark Details


Serial Number

No 87899064

Mark Type

No Service Mark

Attorney Docket Number

No 90125.00040

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Dec 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
21st Jan 2020REGISTERED-PRINCIPAL REGISTER
17th Dec 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
16th Dec 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10th Dec 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
10th Dec 2019STATEMENT OF USE PROCESSING COMPLETE
03rd Dec 2019USE AMENDMENT FILED
03rd Dec 2019TEAS STATEMENT OF USE RECEIVED
04th Jun 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09th Apr 2019PUBLISHED FOR OPPOSITION